CIK 0001815442
- Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812992166
- Phone
- +1 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3ASR Offering Registration Statement
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- DEFA14A Proxy Proxy Materials
- DRS Other Draft Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
Page 7 of 8 · 147 filings